KRYSTAL SHILO: Open Payments
NPI 1477222107 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,395 in 110 payments from 35 companies in 2025. Trend: 2023 $1,617 · 2024 $2,532 · 2025 $2,395
Food & beverage: $2,240Education: $155
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $267 |
| Tempus AI, Inc | 13 | $208 |
| PFIZER INC. | 9 | $187 |
| BeOne Medicines USA, Inc. | 6 | $163 |
| Daiichi Sankyo Inc. | 7 | $161 |
| E.R. Squibb & Sons, L.L.C. | 11 | $144 |
| Merck Sharp & Dohme LLC | 5 | $109 |
| AstraZeneca Pharmaceuticals LP | 4 | $88 |
| ABBVIE INC. | 4 | $84 |
| JAZZ PHARMACEUTICALS INC. | 3 | $82 |
Products named: XT CDX, BRUKINSA, RYBREVANT, OPDIVO, KEYTRUDA, ERLEADA, BESREMI, Enhertu.
Industry payments across TX — which companies pay providers there.
